SERA Stock: Sera Prognostics, Inc. Stock Price, Analysis & Insights
Get live sera stock price $3.55, comprehensive Sera Prognostics, Inc. stock analysis, charts, news, and expert forecast. Real-time sera stock data and investment insights.
Loading chart...
Company Overview
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Company Information
- CEO
- Zhenya Lindgardt
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 63
Contact Information
- Website
- https://seraprognostics.com
- Address
- 2749 East Parleys Way
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Sera Prognostics, Inc. operates in the Medical - Diagnostics & Research industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Zhenya Lindgardt, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Diagnostics & Research model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Sera Prognostics, Inc. competes in the Medical - Diagnostics & Research within the broader Healthcare. With 133.6 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Market, Sera Prognostics, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Sera Prognostics, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Sera Prognostics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Sera Prognostics, Inc.
- ⚠Investors should consider how Sera Prognostics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
133.58M
P/E Ratio
-4.67
Beta
0.98
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 133.58M market capitalization
- Trading Volume: 660 shares traded today
- Price Range: 52-week range of $1.37 - $9.13
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for Sera Prognostics, Inc.
Sera Prognostics, Inc. (SERA) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 133.58M, the company represents a significant player in its market. The stock is currently trading at $3.55 with a negativedaily change of 0.28%.
The company's 63 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -4.67, beta of 0.98, and 52-week price range from $1.37 to $9.13when evaluating investment opportunities.
Why Invest in Sera Prognostics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under Zhenya Lindgardt
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.